| 淡江大學 |
2020-05-13 |
Borrower capital, shadow insurance, and life insurer performance
|
Lin, Jyh-Horng;Huang, Fu-Wei;Chang, Chuen-Ping |
| 國立臺灣師範大學 |
2014-12-02T06:34:24Z |
Borrowing ideas from other nations in Taiwan’s educational reform movement: The case of vouchers.
|
Sheu, T. M. |
| 國立臺灣師範大學 |
2014-12-02T06:34:24Z |
Borrowing ideas from other nations in Taiwan’s educational reform movement: The case of vouchers.
|
Sheu, T. M. |
| 淡江大學 |
2022-05-28 |
Borrowing-Firm Emission Trading, Bank Rate-Setting Behavior, and Carbon-Linked Lending under Capital Regulation
|
Chen, Shi;Huang, Fu-Wei;Lin, Jyh-Horng |
| 淡江大學 |
2023-03 |
Borrowing-firm environmental impact on insurer green finance assessment: Green loan subsidy, regulatory cap, and green technology
|
Li, Xuelian;Chen, Lingzhi;Lin, Jyh-Horng |
| 臺大學術典藏 |
2018-09-10T14:54:18Z |
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
|
Kao, C.;Chao, A.;Tsai, C.-L.;Chuang, W.-C.;Huang, W.-P.;Chen, G.-C.;Lin, C.-Y.;Wang, T.-H.;Wang, H.-S.;Lai, C.-H.; Kao, C.; Chao, A.; Tsai, C.-L.; Chuang, W.-C.; Huang, W.-P.; Chen, G.-C.; Lin, C.-Y.; Wang, T.-H.; Wang, H.-S.; Lai, C.-H.; WEI-PANG HUANG |
| 臺大學術典藏 |
2020-05-12T06:43:09Z |
Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A
|
Huang C.-Y.; CHIA-CHENG WEI; Chen K.-C.; Chen H.-J.; Cheng A.-L.; Chen K.-F. |
| 臺大學術典藏 |
2021-05-18T08:20:17Z |
Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A
|
CHAO-YUAN HUANG; Wei C.-C.; Chen K.-C.; Chen H.-J.; Cheng A.-L.; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A
|
Huang C.-Y.; Wei C.-C.; Chen K.-C.; Chen H.-J.; ANN-LII CHENG; Chen K.-F. |
| 臺大學術典藏 |
2022-05-05T03:09:25Z |
Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A
|
CHAO YUAN HUANG; Wei C.-C.; Chen K.-C.; Chen H.-J.; Cheng A.-L.; Chen K.-F. |
| 國立成功大學 |
2018-04-27 |
Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation
|
Wu;Yuan-Hua;Wu;Wun-Syuan;Lin;Li-Ching;Liu;Chiang-Shin;Ho;Sheng-Yow;Wang;Bour-Jr;Huang;Bu-Miin;Yeh;Ya-Ling;Chiu;Hui-Wen;Yang;Wei-Lei;Wang;Ying-Jan |
| 嘉南藥理大學 |
2018-04-27 |
Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation
|
Wu, Yuan-Hua; Wu, Wun-Syuan; Lin, Li-Ching; Liu, Chiang-Shin; Ho, Sheng-Yow; Wang, Bour-Jr; Huang, Bu-Miin; Yeh, Ya-Ling; Chiu, Hui-Wen; Yang, Wei-Lei; Wang, Ying-Jan |
| 國立成功大學 |
2018-04-27 |
Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation
|
Wu, Yuan-Hua;Wu, Wun-Syuan;Lin, Li-Ching;Liu, Chiang-Shin;Ho, Sheng-Yow;Wang, Bour-Jr;Huang, Bu-Miin;Yeh, Ya-Ling;Chiu, Hui-Wen;Yang, Wei-Lei;Wang, Ying-Jan |
| 國立成功大學 |
2018-4-27 |
Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation (代表著作1)
|
吳沅樺; WU, YUAN HUA; Wu, Yuan-Hua;Wu, Wun-Syuan;Lin, Li-Ching;Liu, Chiang-Shin;Ho, Sheng-Yow;Wang, Bour-Jr;Huang, Bu-Miin;Yeh, Ya-Ling;Chiu, Hui-Wen;Yang, Wei-Lei;Wang, Ying-Jan |
| 中國醫藥大學 |
2006-12 |
Bortezomib in refractory diffuse large b cell lymphoma; a case report
|
謝清昀(Ching-Yun Hsieh); 葉士芃(Shih-Peng Yeh); 白禮源(Li-Yuan Bai); 林振源(Chen-Yuan Lin); 黃馨慧(Hsin-Hui Huang); 廖裕民(Yu-Min Liao); 邱昌芳(Chang-Fang Chiu) |
| 國立成功大學 |
2020-01 |
Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency
|
Yao;Hui-Wen;Wang;Li-Chiu;Tsai;Hsien-Yang;Fang;Yi-Hsuan;Zheng;Chunfu;Chen;Shun-Hua;Hsu;Sheng-Min |
| 國立成功大學 |
2020-01-01 |
Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency
|
許聖民; Hsu, Sheng-Min; Yao, Hui-Wen, Wang, Li-Chiu;Tsai, Hsien-Yang;Fang, Yi-Hsuan;Zheng, Chunfu;Chen, Shun-Hua |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 臺大學術典藏 |
2022-08-19T00:21:05Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Chiun Hsu; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen P.-J; Cheng A.-L.; Hsieh H.-P; YEN-SHEN LU; Hsu C.-H; Hsu C; Yeh P.-Y; Cheng A.-L.;Chen P.-J;Hsieh H.-P;Yen-Shen Lu;Hsu C.-H;Hsu C;Yeh P.-Y;Chen K.-F; Chen K.-F |
| 臺大學術典藏 |
2021-07-03T03:34:50Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:22Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG |
